262 related articles for article (PubMed ID: 11401923)
1. Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve).
Alexander FE; Jarrett RF; Cartwright RA; Armstrong AA; Gokhale DA; Kane E; Gray D; Lawrence DJ; Taylor GM
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):705-9. PubMed ID: 11401923
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection.
Sleckman BG; Mauch PM; Ambinder RF; Mann R; Pinkus GS; Kadin ME; Sherburne B; Perez-Atayde A; Thior I; Mueller N
Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1117-21. PubMed ID: 9865430
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents.
Alexander FE; Jarrett RF; Lawrence D; Armstrong AA; Freeland J; Gokhale DA; Kane E; Taylor GM; Wright DH; Cartwright RA
Br J Cancer; 2000 Mar; 82(5):1117-21. PubMed ID: 10737396
[TBL] [Abstract][Full Text] [Related]
4. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
Kuljić-Kapulica N
Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus expression in Hodgkin's disease in Jordan.
Almasri NM; Khalidi HS
Saudi Med J; 2004 Jun; 25(6):770-5. PubMed ID: 15195209
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Hodgkin's lymphoma after infectious mononucleosis.
Hjalgrim H; Askling J; Rostgaard K; Hamilton-Dutoit S; Frisch M; Zhang JS; Madsen M; Rosdahl N; Konradsen HB; Storm HH; Melbye M
N Engl J Med; 2003 Oct; 349(14):1324-32. PubMed ID: 14523140
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.
Chapman AL; Rickinson AB; Thomas WA; Jarrett RF; Crocker J; Lee SP
Cancer Res; 2001 Aug; 61(16):6219-26. PubMed ID: 11507075
[TBL] [Abstract][Full Text] [Related]
9. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma.
Chang ET; Zheng T; Lennette ET; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE
J Infect Dis; 2004 Jun; 189(12):2271-81. PubMed ID: 15181575
[TBL] [Abstract][Full Text] [Related]
11. An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): evidence for a specific association with EBV+ve HD in young adults.
Alexander FE; Lawrence DJ; Freeland J; Krajewski AS; Angus B; Taylor GM; Jarrett RF
Int J Cancer; 2003 Nov; 107(2):298-302. PubMed ID: 12949811
[TBL] [Abstract][Full Text] [Related]
12. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
13. Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico.
Quintanilla-Martínez L; Gamboa-Domńquez A; Gamez-Ledesma I; Angeles-Angeles A; Mohar A
Mod Pathol; 1995 Aug; 8(6):675-9. PubMed ID: 8532705
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin's disease.
Jarrett RF; MacKenzie J
Semin Hematol; 1999 Jul; 36(3):260-9. PubMed ID: 10462326
[TBL] [Abstract][Full Text] [Related]
15. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.
Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S
J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
[TBL] [Abstract][Full Text] [Related]
17. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
18. Study of association of Epstein Barr-virus with Hodgkin's disease.
Radha K; Shanthi P; Madhavan M; Senthamarai A
Indian J Pathol Microbiol; 1997 Jul; 40(3):351-4. PubMed ID: 9354006
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus in Hodgkin's disease.
Herbst H
Semin Cancer Biol; 1996 Aug; 7(4):183-9. PubMed ID: 8946602
[TBL] [Abstract][Full Text] [Related]
20. Childhood Hodgkin's disease in the United States: an analysis of histologic subtypes and association with Epstein-Barr virus.
Andriko JA; Aguilera NS; Nandedkar MA; Abbondanzo SL
Mod Pathol; 1997 Apr; 10(4):366-71. PubMed ID: 9110300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
